Article Text

Download PDFPDF

P094/306  The PEGASUS stent system for stent assisted coiling of cerebral aneurysms – a multicenter case series
  1. Donald Lobsien1,
  2. Markus Holtmannspötter2,
  3. Florian Eff2,
  4. Berlis Ansgar3,
  5. Christoph J Maurer3,
  6. Daniel Behme4,
  7. Elie Diamandis4,
  8. Ciro Princiotta5,
  9. Luigi Cirillo5,
  10. Massimo Dall’olio5,
  11. Peter Keston6,
  12. Joachim Klisch1,
  13. Alberto Nania6
  1. 1Helios Hospital Erfurt, Diagnostic and Interventional Radiology and Neuroradiology, Erfurt, Germany
  2. 2Klinikum Nuernberg, Diagnostic and Interventional Neuroradiology, Nuernberg, Germany
  3. 3University Hospital Augsburg, Diagnostic and Interventional Radiology and Neuroradiology, Augsburg, Germany
  4. 4University Hospital Magdeburg, Diagnostic and Interventional Neuroradiology, Magdeburg, Germany
  5. 5Institute of Neurological Sciences , Neuroradiology, Bologna, Italy
  6. 6NHS Lothian, Edinburgh, UK


Introduction In this retrospective case series we evaluated stent-assisted coiling with a new low profile lasercut stent (pegasus, Phenox gmbh, Bochum, Germany)

Aim of Study To evaluate the performance of the pegasus stent system for aneurysm treatment.

Methods Patients treated with stent assisted coiling for intracranial aneurysm(s), with or without acute subarachnoid hemorrhage were included into the study. Clinical, imaging, procedural parameters and clinical and imaging follow up parameters were recorded and statistically evaluated.

Results 54 Aneurysms in 53 patients from 6 centers were included into the study. Mean age was 57 years (+-11,68). 29 patients were treated electively, 24 acutely (23 SAH, one partially thrombosed aneurysm with ischemic events). Intracranial procedure related events were recorded in 1 (6,9%) elective patient and in 3 SAH (12,5%) patients. Postprocedural ischemic complications occurred in 3 (12,5%) of the SAH patients and in 1 of the elective patients (3,45%), the latter not changing the mRS of the patient. Overall aneurysm occlusion was Raymond Roy (RR) I in 36 cases, RR II in 9 and RR IIIa in 9 cases and all stents were patent on final DSA run. On the first control which was available for 23 patients after 147,7 days (+-59,6) RR I was achieved in 22, RR II in 1 patient.

Conclusion Stent assisted coiling with the pegasus stent system seems safe and effective.

Disclosure of Interest DL: Money paid to Institution by Phenox GmbH

JK: Procotor for Phenox GmbH disclosures of the other authors will be delivered as soon as possible (too close to deadline)

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.